Pipeline Program
Acne Vulgaris
Key Facts
About matrisys-bioscience
MatriSys Bioscience is a private, pre-revenue biotech company leveraging a proprietary discovery platform to develop topical live biotherapeutics from beneficial skin bacteria. Its lead program targets atopic dermatitis, with additional candidates for acne, Netherton syndrome, and other disorders, addressing a significant unmet need in dermatology. The company is led by a seasoned team with strong scientific roots in skin immunology and microbiome research from UCSD and extensive drug development experience. MatriSys aims to reduce reliance on steroids and immunosuppressants by restoring the natural skin microbiome.
View full company profileAbout matrisys-bioscience
MatriSys Bioscience is a private, pre-revenue biotech company leveraging a proprietary discovery platform to develop topical live biotherapeutics from beneficial skin bacteria. Its lead program targets atopic dermatitis, with additional candidates for acne, Netherton syndrome, and other disorders, addressing a significant unmet need in dermatology. The company is led by a seasoned team with strong scientific roots in skin immunology and microbiome research from UCSD and extensive drug development experience. MatriSys aims to reduce reliance on steroids and immunosuppressants by restoring the natural skin microbiome.
View full company profile